| Year |
Citation |
Score |
| 2024 |
Qie S, Xiong H, Liu Y, Yan C, Wang Y, Tian L, Wang C, Sang N. Stanniocalcin 2 governs cancer cell adaptation to nutrient insufficiency through alleviation of oxidative stress. Research Square. PMID 38464261 DOI: 10.21203/rs.3.rs-3904465/v1 |
0.414 |
|
| 2022 |
Qie S, Sang N. Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target. Journal of Experimental & Clinical Cancer Research : Cr. 41: 161. PMID 35501821 DOI: 10.1186/s13046-022-02370-w |
0.72 |
|
| 2019 |
He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S. Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells. Cancer Management and Research. 11: 6411-6424. PMID 31372045 DOI: 10.2147/Cmar.S197607 |
0.766 |
|
| 2019 |
Qie S, He D, Sang N. Overview of Glutamine Dependency and Metabolic Rescue Protocols. Methods in Molecular Biology (Clifton, N.J.). 1928: 427-439. PMID 30725468 DOI: 10.1007/978-1-4939-9027-6_22 |
0.754 |
|
| 2017 |
He D, Yin C, Qie S, Chen S, Sang N. Abstract 3562: A novel TGF-β signaling pathway promotes a slow growing phenotype of cancer cells in response to glutamine insufficiency Cancer Research. 77: 3562-3562. DOI: 10.1158/1538-7445.Am2017-3562 |
0.758 |
|
| 2016 |
Yin C, He D, Chen S, Tan X, Sang N. Exogenous pyruvate facilitates cancer cell adaptation to hypoxia by serving as an oxygen surrogate. Oncotarget. PMID 27374086 DOI: 10.18632/Oncotarget.10202 |
0.724 |
|
| 2016 |
Chen S, Sang N. Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells. Journal of Cellular Biochemistry. 117: 267-78. PMID 26206147 DOI: 10.1002/jcb.25283 |
0.672 |
|
| 2016 |
Yin C, He D, Chen S, Sang N. Abstract 2802: Exogenous pyruvate supports oxygen-independent tumor cell proliferation by serving as an oxygen surrogate to maintain homeostasis of NAD+/NADH Cancer Research. 76: 2802-2802. DOI: 10.1158/1538-7445.Am2016-2802 |
0.666 |
|
| 2015 |
Chen S, Yin C, Lao T, Liang D, He D, Wang C, Sang N. AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol. Cell Cycle (Georgetown, Tex.). 1-17. PMID 26061431 DOI: 10.1080/15384101.2015.1055426 |
0.775 |
|
| 2015 |
Hu T, He N, Yang Y, Yin C, Sang N, Yang Q. DEC2 expression is positively correlated with HIF-1 activation and the invasiveness of human osteosarcomas. Journal of Experimental & Clinical Cancer Research : Cr. 34: 22. PMID 25884381 DOI: 10.1186/S13046-015-0135-8 |
0.471 |
|
| 2015 |
Lin A, Truong B, Pappas A, Kirifides L, Oubarri A, Chen S, Lin S, Dobrynin D, Fridman G, Fridman A, Sang N, Miller V. Uniform Nanosecond Pulsed Dielectric Barrier Discharge Plasma Enhances Anti-Tumor Effects by Induction of Immunogenic Cell Death in Tumors and Stimulation of Macrophages Plasma Processes and Polymers. 12: 1392-1399. DOI: 10.1002/Ppap.201500139 |
0.647 |
|
| 2014 |
Lin S, Guo Q, Wen J, Li C, Lin J, Cui X, Sang N, Pan J. Survival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas. Journal of Experimental & Clinical Cancer Research : Cr. 33: 26. PMID 24606961 DOI: 10.1186/1756-9966-33-26 |
0.322 |
|
| 2014 |
Qie S, Chu C, Li W, Wang C, Sang N. ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation. Journal of Cellular Biochemistry. 115: 498-509. PMID 24122876 DOI: 10.1002/Jcb.24684 |
0.748 |
|
| 2014 |
Chen S, Yin C, Lao T, Liang D, Sang N. Abstract LB-124: Histone deacetylase 5 stabilizes HIF-1α through Hsp70 deacetylation in cytosol Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-124 |
0.759 |
|
| 2013 |
St Laurent G, Shtokalo D, Dong B, Tackett MR, Fan X, Lazorthes S, Nicolas E, Sang N, Triche TJ, McCaffrey TA, Xiao W, Kapranov P. VlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer. Genome Biology. 14: R73. PMID 23876380 DOI: 10.1186/Gb-2013-14-7-R73 |
0.323 |
|
| 2013 |
Qie S, Tian L, Wang C, Sang N. Abstract LB-135: Stanniocalcin 2 attenuates tumor cell proliferation but suppresses apoptosis in nutrient-deprived conditions. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-135 |
0.772 |
|
| 2012 |
Qie S, Liang D, Yin C, Gu W, Meng M, Wang C, Sang N. Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming. Cell Cycle (Georgetown, Tex.). 11: 3679-90. PMID 22935705 DOI: 10.4161/Cc.21944 |
0.75 |
|
| 2012 |
Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T, Zhong Z, McCue PA, Sang N, Ji JY, Kong B, Jiang J, Wang C. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Cell Cycle (Georgetown, Tex.). 11: 2348-58. PMID 22672904 DOI: 10.4161/Cc.20811 |
0.508 |
|
| 2012 |
Yin C, Qie S, Sang N. Carbon source metabolism and its regulation in cancer cells. Critical Reviews in Eukaryotic Gene Expression. 22: 17-35. PMID 22339657 DOI: 10.1615/Critreveukargeneexpr.V22.I1.20 |
0.753 |
|
| 2012 |
Lao T, Chen S, Sang N. Two mutations impair the stability and function of ubiquitin-activating enzyme (E1). Journal of Cellular Physiology. 227: 1561-8. PMID 21678405 DOI: 10.1002/Jcp.22870 |
0.745 |
|
| 2012 |
Qie S, Chu C, Li W, Wang C, Reginato M, Sang N. Abstract 5143: ErbB2 activation up-regulates glutaminase 1 expression via NF-κB pathway Cancer Research. 72: 5143-5143. DOI: 10.1158/1538-7445.Am2012-5143 |
0.756 |
|
| 2012 |
Chen S, Ying C, Liang D, Jethava N, Sang N. Abstract 4733: Function of cytoplasmic histone deacetylase 5 is required for HIF-1α stability Cancer Research. 72: 4733-4733. DOI: 10.1158/1538-7445.Am2012-4733 |
0.69 |
|
| 2011 |
Qie S, Sang N. Release the ink4a/arf growth suppression by "u" and "me"? Cell Cycle (Georgetown, Tex.). 10: 185-6. PMID 21239875 DOI: 10.4161/Cc.10.2.14471 |
0.769 |
|
| 2011 |
Chen S, Sang N. Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors. Journal of Biomedicine & Biotechnology. 2011: 197946. PMID 21151670 DOI: 10.1155/2011/197946 |
0.709 |
|
| 2010 |
Meng M, Chen S, Lao T, Liang D, Sang N. Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells. Cell Cycle (Georgetown, Tex.). 9: 3921-32. PMID 20935507 DOI: 10.4161/Cc.9.19.13139 |
0.769 |
|
| 2006 |
Liang D, Kong X, Sang N. Effects of histone deacetylase inhibitors on HIF-1. Cell Cycle (Georgetown, Tex.). 5: 2430-5. PMID 17102633 DOI: 10.4161/Cc.5.21.3409 |
0.427 |
|
| 2006 |
Fath DM, Kong X, Liang D, Lin Z, Chou A, Jiang Y, Fang J, Caro J, Sang N. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha. The Journal of Biological Chemistry. 281: 13612-9. PMID 16543236 DOI: 10.1074/Jbc.M600456200 |
0.417 |
|
| 2006 |
Kong X, Lin Z, Liang D, Fath D, Sang N, Caro J. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Molecular and Cellular Biology. 26: 2019-28. PMID 16507982 DOI: 10.1128/Mcb.26.6.2019-2028.2006 |
0.359 |
|
| 2004 |
Severino A, Baldi A, Cottone G, Han M, Sang N, Giordano A, Mileo AM, Paggi MG, De Luca A. RACK1 is a functional target of the E1A oncoprotein. Journal of Cellular Physiology. 199: 134-9. PMID 14978742 DOI: 10.1002/Jcp.10448 |
0.447 |
|
| 2002 |
Sang N, Fang J, Srinivas V, Leshchinsky I, Caro J. Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Molecular and Cellular Biology. 22: 2984-92. PMID 11940656 DOI: 10.1128/Mcb.22.9.2984-2992.2002 |
0.344 |
|
| 2002 |
Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. The Journal of Biological Chemistry. 277: 6183-7. PMID 11744734 DOI: 10.1074/jbc.M110978200 |
0.352 |
|
| 2002 |
Sang N, Caro J, Giordano A. Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses. Frontiers in Bioscience. 7: 407-413. DOI: 10.2741/A784 |
0.4 |
|
| 2001 |
Sang N, Severino A, Russo P, Baldi A, Giordano A, Mileo AM, Paggi MG, De Luca A. RACK1 interacts with E1A and rescues E1A-induced yeast growth inhibition and mammalian cell apoptosis. The Journal of Biological Chemistry. 276: 27026-33. PMID 11358958 DOI: 10.1074/Jbc.M010346200 |
0.45 |
|
| 1998 |
Sang N, Claudio PP, Fu Y, Horikoshi N, Graeven U, Weinmann R, Giordano A. Transforming region of 243R E1A contains two overlapping but distinct transactivation domains. Dna and Cell Biology. 16: 1321-33. PMID 9407004 DOI: 10.1089/Dna.1997.16.1321 |
0.331 |
|
| 1997 |
Sang N, Avantaggiati ML, Giordano A. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity. Journal of Cellular Biochemistry. 66: 277-85. PMID 9257185 DOI: 10.1002/(Sici)1097-4644(19970901)66:3<277::Aid-Jcb1>3.0.Co;2-M |
0.32 |
|
| 1997 |
Puri PL, Avantaggiati ML, Balsano C, Sang N, Graessmann A, Giordano A, Levrero M. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. The Embo Journal. 16: 369-83. PMID 9029156 DOI: 10.1093/Emboj/16.2.369 |
0.356 |
|
| 1996 |
MacLachlan TK, Sang N, Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Critical Reviews in Eukaryotic Gene Expression. 5: 127-56. PMID 8845581 DOI: 10.1615/Critreveukargeneexpr.V5.I2.20 |
0.435 |
|
| Show low-probability matches. |